Clinical trial
POISE Trial: Perioperative Ischemic Evaluation Study
NCT00182039 · Hamilton Health Sciences Corporation, Other · Terminated
Key facts
| NCT number | NCT00182039 |
|---|---|
| Title | POISE Trial: Perioperative Ischemic Evaluation Study |
| Official title | Perioperative Ischemic Evaluation Study (POISE) Trial |
| Acronym | POISE |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) National Health and Medical Research Council, Australia British Heart Foundation AstraZeneca Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Metoprolol controlled release (CR), Placebo |
| Enrollment | 8,351 |
| Start date | Oct 1, 2002 |
| Primary completion | Jul 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 11, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: